Gene clues could predict who benefits from Light-Based therapy for transplant rejection

This study looks at gene activity in blood cells from 30 kidney or lung transplant patients who have chronic rejection. Researchers want to find out why some patients respond well to a treatment called extracorporeal photoapheresis (ECP), which uses light to treat the blood. By comparing gene profiles of responders and non-responders, they hope to identify molecular pathways linked to treatment success. The goal is to better understand the disease, not to test a new cure.